Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohortAndrea Serafin, Andrea Visentin, Alessandro Sanna et al.|Blood Advances|2025Cited by 3
Comparison of Familial Versus Sporadic Forms of Chronic Lymphocytic Leukemia: An Italian Multicenter Case-Control StudyAlberto Fresa, Luca Laurenti, Idanna Innocenti et al.|Blood|2024Cited by 0
Baseline Characteristics from CLL-ZANU2024, an Italian Non-Interventional Study Assessing the Real-World Use of Zanubrutinib in the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)Enrica Antonia Martino, Federico Vozzella, Raffaella Pasquale et al.|Blood|2024Cited by 0
A landscape of genetic heterogeneity in germline predisposition to familial chronic lymphocytic leukemiaLuca Laurenti, Dimitar G. Efremov, Eugenio Sangiorgi et al.|Research Square|2025Cited by 0